Study of long-term effects of covid-19
Part of Infections, Lungs & breathing clinical trials.
This study looks at the long-term effects of COVID-19, sometimes called Long COVID. By studying saliva and health info, researchers hope to understand why some people have lasting symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a positive COVID-19 test at some point
- You are between 18 and 75 years old
- You are willing to answer questionnaires and do study procedures
- You do not have severe gum disease with bleeding gums
- You do not have current mouth sores, oral herpes, or thrush
- You have not had a mouth infection in the last 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who had COVID-19 to learn how the illness can affect health over the long term. It may help researchers understand lasting symptoms and who is at higher risk, which could improve future care.
This study looks at how COVID-19 can affect health and quality of life over the long term. It may help researchers understand symptoms that can last and what changes people experience after recovery.
This trial studies people with mild to moderate COVID-19 symptoms to better understand and help “post-COVID” condition (ongoing effects after infection). You may be eligible if you’re an adult with a recent confirmed COVID-19 test and you agreed to take part.
This study looks at what factors may make COVID-19 symptoms or infection effects last after someone has recovered. It also collects certain body samples to better understand why this persistence happens.
This study looks at what happens to your thinking and daily health after COVID-19, especially if you have sleep apnea. It aims to find out who is more likely to have ongoing problems.
This study follows adults who recently recovered from COVID-19 to better understand what happens during recovery and afterward. It may help researchers identify who is at risk for longer-lasting symptoms (often called “PASC”) and what changes over time.
Hear when a new SARS CoV-2 Post-Acute Sequelae trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.